RESUMO
Granulomas are frequently encountered by pathologists in all types of lung specimens and arise from diverse etiologies. They should always be reported as necrotizing or non-necrotizing, with microorganism stains performed to evaluate for infection. With attention to distribution, quality (poorly vs well-formed), associated features, and correlation with clinical, radiologic, and laboratory data, the differential diagnosis for granulomatous lung disease can usually be narrowed to a clinically helpful "short list." This review describes a practical approach to pulmonary granulomas and reviews the clinicopathological aspects of common entities, including infectious (mycobacteria, fungi) and noninfectious (hypersensitivity pneumonitis, sarcoid, and vasculitis) causes.
Assuntos
Pneumopatias , Humanos , Diagnóstico Diferencial , Pneumopatias/patologia , Pneumopatias/diagnóstico , Granuloma do Sistema Respiratório/patologia , Granuloma do Sistema Respiratório/diagnóstico , Granuloma/patologia , Granuloma/diagnóstico , Pulmão/patologia , Alveolite Alérgica Extrínseca/diagnóstico , Alveolite Alérgica Extrínseca/patologia , Sarcoidose Pulmonar/patologia , Sarcoidose Pulmonar/diagnóstico , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/patologiaAssuntos
Granuloma do Sistema Respiratório , Pneumopatias , Pneumonia , Humanos , Granuloma/diagnóstico por imagem , Granuloma/patologia , Radiografia , Pneumopatias/diagnóstico por imagem , Pneumopatias/patologia , Hialina , Granuloma do Sistema Respiratório/diagnóstico por imagem , Granuloma do Sistema Respiratório/patologiaRESUMO
Lactoferrin (LTF), an iron binding protein, is known to exhibit immune modulatory effects on pulmonary pathology during insult-induced models of primary Mycobacterium tuberculosis (Mtb) infection. The effects of LTF correlate with modulation of the immune related development of the pathology, and altering of the histological nature of the physically compact and dense lung granuloma in mice. Specifically, a recombinant human version of LTF limits immediate progression of granulomatous severity following administration of the Mtb cell wall mycolic acid, trehalose 6,6'-dimycolate (TDM), in part through reduced pro-inflammatory responses known to control these events. This current study investigates a limited course of LTF to modulate not only initiation, but also maintenance and resolution of pathology post development of the granulomatous response in mice. Comparison is made to a fusion of LTF with the Fc domain of IgG2 (FcLTF), which is known to extend LTF half-life in circulation. TDM induced granulomas were examined at extended times post insult (day 7 and 14). Both LTF and the novel FcLTF exerted sustained effects on lung granuloma pathology. Reduction of pulmonary pro-inflammatory cytokines TNF-α and IL-1ß occurred, correlating with reduced pathology. Increase in IL-6, known to regulate granuloma maintenance, was also seen with the LTFs. The FcLTF demonstrated greater impact than the recombinant LTF, and was superior in limiting damage to pulmonary tissues while limiting residual inflammatory cytokine production.
Assuntos
Fatores Corda , Granuloma do Sistema Respiratório , Lactoferrina , Pneumopatias , Animais , Humanos , Camundongos , Fatores Corda/metabolismo , Fatores Corda/toxicidade , Lactoferrina/uso terapêutico , Mycobacterium tuberculosis/metabolismo , Granuloma do Sistema Respiratório/induzido quimicamente , Granuloma do Sistema Respiratório/tratamento farmacológico , Pneumopatias/induzido quimicamente , Pneumopatias/tratamento farmacológicoRESUMO
A granulomatose com poliangeíte (GPA) é uma vasculite de pequenos vasos, de acometimento sistêmico variável, sendo o trato respiratório superior, inferior e rins os órgãos mais afetados. O acometimento traqueobrônquico se dá por várias manifestações, sendo a estenose subglótica a manifestação mais comum. A apresentação da estenose pode ser independente das manifestações sistêmicas da GPA e nem sempre segue a mesma evolução e resposta ao tratamento dos demais órgãos acometidos por essa vasculite, podendo ser grave o suficiente para necessitar de traqueostomia. Este estudo tem como objetivo relatar um caso de GPA com evolução para estenose subglótica (ESG) de 60% da luz da traqueia e o comportamento desta complicação frente às opções terapêuticas utilizadas. É um estudo observacional, descritivo, do tipo relato de caso. O caso demonstra a complexidade dessa apresentação clínica frente às opções terapêuticas disponíveis, por vezes, necessitando da combinação de medidas farmacológicas e intervencionistas. O manejo bem-sucedido da ESG é essencial para evitar complicações graves, destacando a importância do diagnóstico precoce e do acompanhamento rigoroso para garantir a qualidade de vida dos pacientes afetados por essa condição desafiadora. Palavra-chave: Estenose subglótica. Granulomatose com poliangeíte. Granulomatose de Wegener.
Assuntos
Humanos , Feminino , Adulto , Vasculite/complicações , Granuloma do Sistema Respiratório , Granulomatose com Poliangiite/diagnósticoRESUMO
INTRODUCTION: Large vessels are often encountered during endobronchial ultrasound (EBUS). Safety of traversing the vessels weighed against a more invasive procedure can be a dilemma. MATERIAL AND METHODS: We describe a case series of 8 patients who underwent transvascular needle aspiration during EBUS, to access a lesion in the absence of an alternate safe window. A 21 gauge EBUS needle was used to traverse either the main or a major branch of the pulmonary artery. RESULTS: Malignancy was suspected at ROSE in five cases. Granuloma and necrosis noted in 2 cases were confirmed as tubercu-losis on culture. Diagnostic yield of EBUS-TVNA was 87.5% (7/8). No complications were noted in the immediate post-operative period as well as during 6 months of follow up. CONCLUSION: EBUS-TVNA in carefully selected patients is a feasible alternative to more invasive procedures with excellent yield. Appropriate intraoperative, perioperative and postoperative monitoring and care must be available in the case of fatal bleeds.
Assuntos
Aspiração por Agulha Fina Guiada por Ultrassom Endoscópico/métodos , Biópsia Guiada por Imagem/métodos , Neoplasias Pulmonares/patologia , Pulmão/patologia , Linfonodos/patologia , Adulto , Feminino , Granuloma do Sistema Respiratório/patologia , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Tuberculosis (TB) is a persistent global pandemic, and standard treatment for it has not changed for 30 years. Mycobacterium tuberculosis (Mtb) has undergone prolonged coevolution with humans, and patients can control Mtb even after extensive infection, demonstrating the fine balance between protective and pathological host responses within infected granulomas. We hypothesized that whole transcriptome analysis of human TB granulomas isolated by laser capture microdissection could identify therapeutic targets, and that comparison with a noninfectious granulomatous disease, sarcoidosis, would identify disease-specific pathological mechanisms. Bioinformatic analysis of RNAseq data identified numerous shared pathways between TB and sarcoidosis lymph nodes, and also specific clusters demonstrating TB results from a dysregulated inflammatory immune response. To translate these insights, we compared 3 primary human cell culture models at the whole transcriptome level and demonstrated that the 3D collagen granuloma model most closely reflected human TB disease. We investigated shared signaling pathways with human disease and identified 12 intracellular enzymes as potential therapeutic targets. Sphingosine kinase 1 inhibition controlled Mtb growth, concurrently reducing intracellular pH in infected monocytes and suppressing inflammatory mediator secretion. Immunohistochemical staining confirmed that sphingosine kinase 1 is expressed in human lung TB granulomas, and therefore represents a host therapeutic target to improve TB outcomes.
Assuntos
Granuloma do Sistema Respiratório/metabolismo , Pulmão/metabolismo , Modelos Biológicos , Mycobacterium tuberculosis/metabolismo , RNA-Seq , Tuberculose Pulmonar/metabolismo , Adulto , Idoso , Feminino , Granuloma do Sistema Respiratório/genética , Granuloma do Sistema Respiratório/microbiologia , Granuloma do Sistema Respiratório/patologia , Humanos , Pulmão/microbiologia , Pulmão/patologia , Masculino , Pessoa de Meia-Idade , Tuberculose Pulmonar/genética , Tuberculose Pulmonar/patologiaRESUMO
Tuberculosis (TB) is still a major worldwide health threat and primarily a lung disease. The innate immune response against Mycobacterium tuberculosis (Mtb) is orchestrated by dendritic cells, macrophages, neutrophils, natural killer cells and apparently mast cells (MCs). MCs are located at mucosal sites including the lungs and contribute in host-defence against pathogens, but little is known about their role during Mtb infection. This study investigates the location and characteristics of MCs in TB lesions to assess their contribution to TB pathology. To this purpose, number, location and phenotype of MCs was studied in 11 necropsies of pulmonary TB and 3 necropsies of non-TB infected lungs that were used as controls. MCs were localised at pneumonic areas, in the granuloma periphery and particularly abundant in fibrotic tissue. Furthermore, MCs displayed intracellular Mtb and IL-17A and TGF-ß immunostaining. These findings were validated by analysing, post-mortem lung tissue microarrays from 44 individuals with pulmonary TB and 25 control subjects. In affected lungs, increased numbers of MCs expressing intracellularly both tryptase and chymase were found at fibrotic sites. Altogether, our data suggest that MCs are recruited at the inflammatory site and that actively produce immune mediators such as proteases and TGF-ß that may be contributing to late fibrosis in TB lesions.
Assuntos
Contagem de Leucócitos , Mastócitos/imunologia , Mastócitos/metabolismo , Mycobacterium tuberculosis/imunologia , Tuberculose Pulmonar/imunologia , Tuberculose Pulmonar/microbiologia , Antígenos de Bactérias/imunologia , Fibrose , Granuloma do Sistema Respiratório/patologia , Humanos , Imuno-Histoquímica , Triptases/metabolismoRESUMO
Immune dysregulation, polyendocrinopathy and enteropathy, X-linked (IPEX) syndrome is a rare disorder caused by loss-of-function mutations in the gene forkhead box protein 3 (FOXP3). IPEX patients frequently show chronic diarrhea (enteropathy) associated with villous atrophies in the small intestine. Our case is different from this classical information in the literature, since he presented with neonatal onset inflammatory bowel disease within the first months of life accompanied by deep ulcers throughout colonic mucosa. Moreover, he developed chronic lung disease during follow-up and histopathological examinations showed granulomas in both gastrointestinal tract and lung parenchyma. Genetic analysis revealed the diagnosis of IPEX syndrome with a germline mutation in FOXP3. Thus, our study provides an unusual presentation of IPEX syndrome with colitis and granulomas presence in histopathological examinations.
Assuntos
Colite/patologia , Diabetes Mellitus Tipo 1/congênito , Diarreia/patologia , Doenças Genéticas Ligadas ao Cromossomo X/patologia , Granuloma do Sistema Respiratório/patologia , Doenças do Sistema Imunitário/congênito , Colite/genética , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patologia , Diarreia/genética , Duodeno/patologia , Fatores de Transcrição Forkhead/genética , Doenças Genéticas Ligadas ao Cromossomo X/genética , Granuloma/genética , Granuloma/patologia , Granuloma do Sistema Respiratório/genética , Humanos , Doenças do Sistema Imunitário/genética , Doenças do Sistema Imunitário/patologia , Recém-Nascido , Masculino , MutaçãoRESUMO
Drug adulterants containing contaminants have been known to cause lung disease by inhalation or intravenous intake. Talcosis due to intravenous talc injection has been widely described in the literature, whereas the hypothesis of granulomatosis due to asbestos related to adulterated cocaine injection has not yet been explored. Herein, a case of pulmonary granulomatosis due to asbestos fibres related to cocaine injection in a young woman is described. Inorganic material in the lung was first individuated by light microscopy and last was identified using the SEM-EDX method. This case is unique since the occupational and passive inhalation of asbestos was excluded with absolute certainty.
Assuntos
Amianto/efeitos adversos , Estimulantes do Sistema Nervoso Central/efeitos adversos , Transtornos Relacionados ao Uso de Cocaína/complicações , Cocaína/efeitos adversos , Contaminação de Medicamentos , Granuloma de Corpo Estranho/etiologia , Granuloma do Sistema Respiratório/etiologia , Abuso de Substâncias por Via Intravenosa/complicações , Adulto , Amianto/administração & dosagem , Autopsia , Estimulantes do Sistema Nervoso Central/administração & dosagem , Cocaína/administração & dosagem , Usuários de Drogas , Evolução Fatal , Feminino , Granuloma de Corpo Estranho/patologia , Granuloma do Sistema Respiratório/patologia , HumanosRESUMO
BACKGROUND: Chronic beryllium disease (CBD), a granulomatous disease with similarities to sarcoidosis, arises only in individuals exposed to beryllium. Inhaled beryllium can elicit a T-cell-dominated alveolitis leading nonnecrotizing granulomata. CBD can be distinguished from sarcoidosis by demonstrating beryllium sensitization in a lymphocyte proliferation test. RESEARCH QUESTION: Beryllium exposure usually occurs in an occupational setting. Because of the diagnosis of CBD in a patient without evident beryllium exposure, we performed a beryllium-lymphocyte proliferation test (BeLPT) among his work colleagues. STUDY DESIGN AND METHODS: This field study investigated a cohort of work colleagues without obvious beryllium exposure. Twenty-one of 30 individuals were assessed in our outpatient clinic for beryllium sensitization. Therefore, BeLPT was performed with freshly collected peripheral blood mononuclear cells. Data were extracted from clinical charts, including geographical data. Beryllium content in dust samples collected at the workplace was measured by graphite-furnace atomic absorption spectroscopy and was compared with samples from different areas of Germany. RESULTS: For the initial patient, the diagnosis of sarcoidosis was reclassified as CBD based on two positive BeLPT results. Assessment of his workplace did not identify a source of beryllium. However, BeLPTs performed on his workmates demonstrated beryllium sensitization in 5 of 21 individuals, suggesting a local beryllium source. Concrete dust obtained from the building yard, the workplace of the index patient, contained high amounts of beryllium (1138 ± 162 µg/kg), whereas dust from other localities (control samples) showed much lower beryllium content (range, 147 ± 18-452 ± 206 µg/kg). Notably, the control dust collected from different places all over Germany exhibit different beryllium concentrations. INTERPRETATION: We describe a cluster of beryllium-sensitized workers from an industry not related to beryllium caused by environmental exposure to beryllium-containing concrete dust, which exhibited markedly elevated beryllium content. Importantly, analyses of dust samples collected from different localities showed that they contain markedly different amounts of beryllium. Thus, besides workplace-related exposure, environmental factors also are capable of eliciting a beryllium sensitization.
Assuntos
Beriliose , Berílio , Poeira/análise , Exposição Ambiental , Granuloma do Sistema Respiratório , Ativação Linfocitária/imunologia , Sarcoidose Pulmonar/diagnóstico , Adulto , Beriliose/diagnóstico , Beriliose/etiologia , Beriliose/imunologia , Beriliose/prevenção & controle , Berílio/análise , Berílio/toxicidade , Indústria da Construção , Diagnóstico Diferencial , Exposição Ambiental/efeitos adversos , Exposição Ambiental/análise , Feminino , Alemanha/epidemiologia , Granuloma do Sistema Respiratório/induzido quimicamente , Granuloma do Sistema Respiratório/diagnóstico , Humanos , Testes Imunológicos/métodos , Leucócitos Mononucleares , Masculino , Conglomerados Espaço-Temporais , Local de Trabalho/normasRESUMO
The mechanism by which only some individuals infected with Mycobacterium tuberculosis develop necrotic granulomas with progressive disease while others form controlled granulomas that contain the infection remains poorly defined. Mice carrying the sst1-suscepible (sst1S) genotype develop necrotic inflammatory lung lesions, similar to human tuberculosis (TB) granulomas, which are linked to macrophage dysfunction, while their congenic counterpart (B6) mice do not. In this study we report that (a) sst1S macrophages developed aberrant, biphasic responses to TNF characterized by superinduction of stress and type I interferon pathways after prolonged TNF stimulation; (b) the late-stage TNF response was driven via a JNK/IFN-ß/protein kinase R (PKR) circuit; and (c) induced the integrated stress response (ISR) via PKR-mediated eIF2α phosphorylation and the subsequent hyperinduction of ATF3 and ISR-target genes Chac1, Trib3, and Ddit4. The administration of ISRIB, a small-molecule inhibitor of the ISR, blocked the development of necrosis in lung granulomas of M. tuberculosis-infected sst1S mice and concomitantly reduced the bacterial burden. Hence, induction of the ISR and the locked-in state of escalating stress driven by the type I IFN pathway in sst1S macrophages play a causal role in the development of necrosis in TB granulomas. Interruption of the aberrant stress response with inhibitors such as ISRIB may offer novel host-directed therapy strategies.
Assuntos
Granuloma do Sistema Respiratório/imunologia , Pulmão/imunologia , Mycobacterium tuberculosis/imunologia , Estresse Fisiológico/imunologia , Tuberculose Pulmonar/imunologia , Animais , Modelos Animais de Doenças , Granuloma do Sistema Respiratório/microbiologia , Granuloma do Sistema Respiratório/patologia , Pulmão/microbiologia , Pulmão/patologia , Camundongos , Camundongos SCID , Necrose , Tuberculose Pulmonar/patologiaRESUMO
Background: Granulomatous-lymphocytic interstitial lung disease (GLILD) is a rare, potentially severe pulmonary complication of common variable immunodeficiency disorders (CVID). Informative clinical trials and consensus on management are lacking. Aims: The European GLILD network (e-GLILDnet) aims to describe how GLILD is currently managed in clinical practice and to determine the main uncertainties and unmet needs regarding diagnosis, treatment and follow-up. Methods: The e-GLILDnet collaborators developed and conducted an online survey facilitated by the European Society for Immunodeficiencies (ESID) and the European Respiratory Society (ERS) between February-April 2020. Results were analyzed using SPSS. Results: One hundred and sixty-one responses from adult and pediatric pulmonologists and immunologists from 47 countries were analyzed. Respondents treated a median of 27 (interquartile range, IQR 82-maximum 500) CVID patients, of which a median of 5 (IQR 8-max 200) had GLILD. Most respondents experienced difficulties in establishing the diagnosis of GLILD and only 31 (19%) had access to a standardized protocol. There was little uniformity in diagnostic or therapeutic interventions. Fewer than 40% of respondents saw a definite need for biopsy in all cases or performed bronchoalveolar lavage for diagnostics. Sixty-six percent used glucocorticosteroids for remission-induction and 47% for maintenance therapy; azathioprine, rituximab and mycophenolate mofetil were the most frequently prescribed steroid-sparing agents. Pulmonary function tests were the preferred modality for monitoring patients during follow-up. Conclusions: These data demonstrate an urgent need for clinical studies to provide more evidence for an international consensus regarding management of GLILD. These studies will need to address optimal procedures for definite diagnosis and a better understanding of the pathogenesis of GLILD in order to provide individualized treatment options. Non-availability of well-established standardized protocols risks endangering patients.
Assuntos
Alergia e Imunologia/tendências , Imunodeficiência de Variável Comum/tratamento farmacológico , Granuloma do Sistema Respiratório/tratamento farmacológico , Imunossupressores/uso terapêutico , Doenças Pulmonares Intersticiais/tratamento farmacológico , Pediatria/tendências , Padrões de Prática Médica/tendências , Pneumologia/tendências , Produtos Biológicos/uso terapêutico , Imunodeficiência de Variável Comum/diagnóstico , Imunodeficiência de Variável Comum/imunologia , Europa (Continente) , Granuloma do Sistema Respiratório/diagnóstico , Granuloma do Sistema Respiratório/imunologia , Pesquisas sobre Atenção à Saúde , Disparidades em Assistência à Saúde/tendências , Humanos , Imunossupressores/efeitos adversos , Internet , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/imunologia , Pediatras/tendências , Prognóstico , Pneumologistas/tendências , Esteroides/uso terapêutico , Estados UnidosRESUMO
BACKGROUND: This study aimed to report the experience of diagnosis and treatment of one rare case of mediastinal lymph node tuberculous abscess (MLNTA) using endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). CASE PRESENTATION: An 18-year-old female patient was hospitalized in the Affiliated Hospital of Xuzhou Medical University in November 2017, due to intermittent left chest pain. She was suspected of infecting tuberculosis (TB) and thus received anti-TB treatment. Since April 1, 2018, she began to exhibit symptoms of chest distress. The patient was then admitted to Shanghai Pulmonary Hospital and continued receiving systemic anti-TB treatment during the whole course. On April 11, 2018, she received EBUS-TBNA to puncture pus and inject isoniazid. Simultaneously, the pus was sent for cytopathological and bacteriological examination, both supporting the diagnosis of TB in the patient. On April 24 and May 10, she received two times of EBUS-TBNA treatment. The symptoms of chest distress were relieved, but granulomatous neoplasm occurred at the EBUS-TBNA site on the trachea wall. The patient then received local clamp removal and cryotherapy on May 29 and Jul 19, respectively. Chest computed tomography (CT) reexamination on September 28 revealed that the MLNTA lesion had been completely absorbed, and electronic bronchoscopic reexamination on September 30 demonstrated that the granulomatous neoplasm on the trachea wall was entirely invisible. CONCLUSIONS: Using EBUS-TBNA to puncture and aspirate pus and inject drugs can be effectively used to diagnose and treat MLNTA, which provides a new, less invasive, safe and reliable method for diagnosis and treatment of MLNTA.
Assuntos
Abscesso/diagnóstico , Abscesso/terapia , Aspiração por Agulha Fina Guiada por Ultrassom Endoscópico , Tuberculose dos Linfonodos/diagnóstico , Tuberculose dos Linfonodos/tratamento farmacológico , Abscesso/microbiologia , Adolescente , Antituberculosos/uso terapêutico , Broncoscopia , Feminino , Granuloma do Sistema Respiratório/diagnóstico por imagem , Granuloma do Sistema Respiratório/cirurgia , Humanos , Injeções Intralesionais , Isoniazida/uso terapêutico , Linfonodos/patologia , Mediastino , Doenças da Traqueia/diagnóstico por imagem , Doenças da Traqueia/cirurgia , Tuberculose dos Linfonodos/complicaçõesRESUMO
CASE PRESENTATION: A 52-year-old man, current smoker with a 50 pack-year history, presented to our department with cough, yellow sputum, and localized right chest pain. Chest radiograph revealed a large mass in the right upper lobe. He denied the presence of fever, night sweats, or weight loss. He has a medical history of COPD and anxiety disorder. He was receiving long-acting beta agonists/long-acting muscarinic antagonists as a treatment for COPD and quetiapine 100 mg for anxiety disorder.
Assuntos
Dor no Peito , Tosse , Granuloma do Sistema Respiratório , Pulmão , Pneumonectomia/métodos , Toracotomia/métodos , Biópsia/métodos , Dor no Peito/diagnóstico , Dor no Peito/etiologia , Tosse/diagnóstico , Tosse/etiologia , Diagnóstico Diferencial , Granuloma do Sistema Respiratório/diagnóstico por imagem , Granuloma do Sistema Respiratório/fisiopatologia , Granuloma do Sistema Respiratório/cirurgia , Humanos , Inflamação , Pulmão/diagnóstico por imagem , Pulmão/patologia , Masculino , Pessoa de Meia-Idade , Necrose , Radiografia Torácica/métodos , Nódulo Pulmonar Solitário/diagnóstico , Tomografia Computadorizada por Raios X/métodos , Resultado do TratamentoRESUMO
BACKGROUND: Forms of interstitial pneumonia secondary to exposure to an air-contaminant are varied and so far, insufficiently described. OBJECTIVES/METHODS: We report here a case of a 57-year-old patient managed in our department for the exploration of MRC grade 2 dyspnoea and interstitial pneumonia. He mentioned multiple occupational and domestic exposures such as hens' excrements, asbestos and metal particles; he also had a previous history of smoking. RESULTS: High-resolution computed tomography showed ground glass opacities predominating in posterior territories and surrounding cystic lesions or emphysematous destruction. The entire etiological assessment revealed only macrophagic alveolitis with giant multinucleated cells on the bronchoalveolar lavage. A surgical lung biopsy allowed us to refine the diagnosis with evidence of desquamative interstitial pneumonia and pulmonary granulomatosis. Finally, the analysis of the mineral particles in the biopsy revealed abnormally high rates of Zirconium and Aluminium. We were therefore able to conclude to a desquamative interstitial pneumonia associated with pulmonary granulomatosis linked to metal exposure (Aluminium and Zirconium). The clinical, functional and radiological evolution was favorable after a systemic corticosteroid treatment with progressive decay over one year. CONCLUSION: This presentation reports the first case to our knowledge of desquamative interstitial pneumonitis related to exposure to Zirconium and the third one in the context of Aluminium exposure. The detailed analysis of the mineral particles present on the surgical lung biopsy allows for the identification of the relevant particle to refine the etiological diagnosis, to guide the therapeutic management and to give access to recognition as an occupational disease. (Sarcoidosis Vasc Diffuse Lung Dis 2020; 37 (1): 79-84).
Assuntos
Alumínio/efeitos adversos , Granuloma do Sistema Respiratório/induzido quimicamente , Exposição por Inalação/efeitos adversos , Doenças Pulmonares Intersticiais/induzido quimicamente , Pulmão/efeitos dos fármacos , Zircônio/efeitos adversos , Corticosteroides/administração & dosagem , Alumínio/análise , Biópsia , Granuloma do Sistema Respiratório/diagnóstico , Granuloma do Sistema Respiratório/tratamento farmacológico , Granuloma do Sistema Respiratório/metabolismo , Humanos , Pulmão/química , Pulmão/diagnóstico por imagem , Pulmão/patologia , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/tratamento farmacológico , Doenças Pulmonares Intersticiais/metabolismo , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Zircônio/análiseRESUMO
No disponible